Is PD-L1 a consistent biomarker for anti-PD-1 therapy? The model of balstilimab in a virally-driven tumor

被引：80

作者：

Grossman, Joseph E. ^{[1
]}

Vasudevan, Divya ^{[1
]}

Joyce, Cailin E. ^{[1
]}

Hildago, Manuel ^{[2
]}

机构：

[1] Agenus Inc, Lexington, MA USA

[2] Weill Cornell Med, Div Hematol & Med Oncol, New York, NY 10065 USA

来源：

ONCOGENE | 2021年 / 40卷 / 08期

关键词：

EXPRESSION; MECHANISM; ESCAPE;

D O I：

10.1038/s41388-020-01611-6

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

070307 [化学生物学]; 071010 [生物化学与分子生物学];

摘要：

引用

页码：1393 / 1395

页数：3

共 23 条

[1]

Biomarkers for immunotherapy in bladder cancer: a moving target [J].

Aggen, David H. ;

Drake, Charles G. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5

[2]

Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors [J].

Akbay, Esra A. ;

Koyama, Shohei ;

Carretero, Julian ;

Altabef, Abigail ;

Tchaicha, Jeremy H. ;

Christensen, Camilla L. ;

Mikse, Oliver R. ;

Cherniack, Andrew D. ;

Beauchamp, Ellen M. ;

Pugh, Trevor J. ;

Wilkerson, Matthew D. ;

Fecci, Peter E. ;

Butaney, Mohit ;

Reibel, Jacob B. ;

Soucheray, Margaret ;

Cohoon, Travis J. ;

Janne, Pasi A. ;

Meyerson, Matthew ;

Hayes, D. Neil ;

Shapiro, Geoffrey I. ;

Shimamura, Takeshi ;

Sholl, Lynette M. ;

Rodig, Scott J. ;

Freeman, Gordon J. ;

Hammerman, Peter S. ;

Dranoff, Glenn ;

Wong, Kwok-Kin .

CANCER DISCOVERY, 2013, 3 (12) :1355-1363

[3]

A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells [J].

Barsoum, Ivraym B. ;

Smallwood, Chelsea A. ;

Siemens, D. Robert ;

Graham, Charles H. .

CANCER RESEARCH, 2014, 74 (03) :665-674

[4]

Pembrolizumab treatment of advanced cervical cancer: Updated results from the phase 2 KEYNOTE-158 study [J].

Chung, Hyun Cheol ;

Schellens, Jan H. M. ;

Delord, Jean-Pierre ;

Perets, Ruth ;

Italiano, Antoine ;

Shapira-Frommer, Ronnie ;

Manzuk, Lyudmila ;

Piha-Paul, Sarina Anne ;

Wang, Jiangdian ;

Zeigenfuss, Susan ;

Pruitt, Scott K. ;

Marabelle, Aurelien .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

[5]

Honokiol-mediated Inhibition of PI3K/mTOR Pathway A Potential Strategy to Overcome Immunoresistance in Glioma, Breast, and Prostate Carcinoma Without Impacting T Cell Function [J].

Crane, Courtney ;

Panner, Amith ;

Pieper, Russell O. ;

Arbiser, Jack ;

Parsa, Andrew T. .

JOURNAL OF IMMUNOTHERAPY, 2009, 32 (06) :585-592

[6]

Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730

[7]

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression [J].

Garcia-Diaz, Angel ;

Shin, Daniel Sanghoon ;

Moreno, Blanca Homet ;

Saco, Justin ;

Escuin-Ordinas, Helena ;

Rodriguez, Gabriel Abril ;

Zaretsky, Jesse M. ;

Sun, Lu ;

Hugo, Willy ;

Wang, Xiaoyan ;

Parisi, Giulia ;

Saus, Cristina Puig ;

Torrejon, Davis Y. ;

Graeber, Thomas G. ;

Comin-Anduix, Begonya ;

Hu-Lieskovan, Siwen ;

Damoiseaux, Robert ;

Lo, Roger S. ;

Ribas, Antoni .

CELL REPORTS, 2017, 19 (06) :1189-1201

[8]

Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy [J].

Green, Michael R. ;

Rodig, Scott ;

Juszczynski, Przemyslaw ;

Ouyang, Jing ;

Sinha, Papiya ;

O'Donnell, Evan ;

Neuberg, Donna ;

Shipp, Margaret A. .

CLINICAL CANCER RESEARCH, 2012, 18 (06) :1611-1618

[9]

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma [J].

Green, Michael R. ;

Monti, Stefano ;

Rodig, Scott J. ;

Juszczynski, Przemyslaw ;

Currie, Treeve ;

O'Donnell, Evan ;

Chapuy, Bjoern ;

Takeyama, Kunihiko ;

Neuberg, Donna ;

Golub, Todd R. ;

Kutok, Jeffery L. ;

Shipp, Margaret A. .

BLOOD, 2010, 116 (17) :3268-3277

[10]

Variation of Programmed Death Ligand 1 Expression After Platinum-based Neoadjuvant Chemotherapy in Lung Cancer [J].

Guo, Lei ;

Song, Peng ;

Xue, Xuemin ;

Guo, Changyuan ;

Han, Liankui ;

Fang, Qing ;

Ying, Jianming ;

Gao, Shugeng ;

Li, Wenbin .

JOURNAL OF IMMUNOTHERAPY, 2019, 42 (06) :215-220

← 1 2 3 →